Most Viewed Articles
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
Review ArticleReactive and proactive treatment in atopic dermatitis: Long-term disease controlFull text |  PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_31_2023 |
13,651 | 87,596 | 101,247 |
EditorialIndian Journal of Skin Allergy – Embracing new horizonsFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_39_2023 |
2,459 | 86,917 | 89,376 |
CommentaryStatus of research and publication in IndiaFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_29_2023 |
4,813 | 75,253 | 80,066 |
EditorialEczema and skin allergy-focus on researchFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_29_2024 |
2,850 | 61,704 | 64,554 |
Case ReportHair depigmentation in a patient treated with pazopanib: A case report and a comprehensive analysisFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_52_2023 |
9,179 | 49,472 | 58,651 |
Original ArticleEfficacy and safety of crisaborole ointment in pediatric atopic dermatitis: A 4-week open-label studyFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_45_2023 |
10,287 | 47,306 | 57,593 |
Letter to EditorMethotrexate in refractory chronic urticariaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_15_2024 |
8,350 | 47,024 | 55,374 |
Review ArticleCutaneous adverse drug reactions in children with a focus on hypersensitivity to systemic drugs: A narrative reviewFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_14_2024 |
8,458 | 40,319 | 48,777 |
Case ReportAmbroxol-induced leukocytoclastic vasculitis: A case report and literature reviewFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_37_2023 |
7,025 | 40,656 | 47,681 |
Review ArticlePigmented contact dermatitis: An updated reviewFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_44_2023 |
23,385 | 23,693 | 47,078 |
Original ArticleComorbidities in patients with chronic urticaria: A cross sectional study from an Urticaria Center of Reference and ExcellenceFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_26_2023 |
8,959 | 32,634 | 41,593 |
SymposiumInvestigations and treatment of photodermatosesFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_6_2024 |
14,540 | 25,949 | 40,489 |
Original ArticleThe effectiveness of bilastine and fexofenadine updosing in the management of chronic spontaneous urticariaFull text | PDF Volume 1 | Issue 2 | July-December 2022DOI: 10.25259/IJSA_3_2021 |
28,595 | 6,140 | 34,735 |
Case ReportPenile angioedema in a child: A nightmare to parents!Full text | PDF Volume 1 | Issue 1 | January-June 2022DOI: 10.25259/IJSA_5_2021 |
24,289 | 10,224 | 34,513 |
Review ArticleJAK inhibitors in dermatologyFull text | PDF Volume 2 | Issue 1 | January-June 2023DOI: 10.25259/IJSA_7_2021 |
22,689 | 9,970 | 32,659 |
SymposiumPhototoxicity and photoallergy – A brief review on pathogenesis, recent advances, and approach to a patient with photosensitivityFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_9_2024 |
15,787 | 15,716 | 31,503 |
SymposiumPolymorphous light eruptionsFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_8_2024 |
15,523 | 14,433 | 29,956 |
Review ArticleGenital contact dermatitisFull text | PDF Volume 4 | Issue 1 | January-June 2025DOI: 10.25259/IJSA_56_2024 |
27,414 | 2,340 | 29,754 |
Resident’s CornerAllergic reactions to radiocontrast media–A brief overviewFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_4_2024 |
9,506 | 17,977 | 27,483 |
Review ArticleAssessing eczema severity: A comprehensive review of scoring systemsFull text | PDF Volume 4 | Issue 1 | January-June 2025DOI: 10.25259/IJSA_50_2024 |
18,564 | 8,044 | 26,608 |
Case ReportPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_3_2024 |
4,335 | 21,821 | 26,156 |
Case ReportA novel pitch against the itchFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_13_2024 |
4,760 | 20,940 | 25,700 |
SymposiumCutaneous photobiologyFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_11_2024 |
9,980 | 13,845 | 23,825 |
Letter to EditorCutaneous vasculitis as the sole clinical feature of primary Sjögren’s syndromeFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_48_2023 |
9,850 | 13,542 | 23,392 |
Original ArticleStudy of effectiveness of methotrexate oral pulse in refractory chronic urticariaFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_28_2023 |
8,157 | 14,796 | 22,953 |
Conference ReportUpcoming dermatology conferences 2025Full text | PDF Volume 4 | Issue 1 | January-June 2025DOI: 10.25259/IJSA_2_2025 |
16,026 | 5,586 | 21,612 |
CommentaryFellowship and mentorship opportunities in allergic skin disorders for Indian dermatologistsFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_30_2023 |
7,706 | 13,640 | 21,346 |
Letter to EditorPost-herpetic neuralgia-associated patchy hair loss closely mimicking trichotillomaniaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_19_2024 |
4,749 | 16,234 | 20,983 |
SymposiumChronic actinic dermatitisFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_10_2024 |
10,351 | 10,099 | 20,450 |
Review ArticleStem-cell therapy in dermatology – Challenges and opportunitiesFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_50_2023 |
11,818 | 8,515 | 20,333 |
Original ArticlePatch testing with Indian standard series of 20 allergens in 125 patients of chronic dermatitis and dermatosesFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_16_2024 |
10,074 | 9,799 | 19,873 |
Review ArticleCyclosporine in dermatology: Evidence-based review with a special focus on recent updatesFull text | PDF Volume 4 | Supplement 1 | March 2025DOI: 10.25259/IJSA_9_2025 |
15,863 | 3,913 | 19,776 |
Review ArticleDigital object identifier: What it is and why it matters?Full text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_20_2023 |
14,585 | 4,960 | 19,545 |
Review ArticleA review of comorbidities in atopic dermatitisFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_37_2024 |
8,327 | 10,678 | 19,005 |
ImageGiant fixed drug eruptionFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_47_2023 |
3,536 | 15,223 | 18,759 |
ObituaryObituary – Professor Marcus Maurer (1966–2024)Full text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_47_2024 |
9,608 | 8,946 | 18,554 |
Letter to EditorComparative real-world clinical assessment of mometasone furoate 0.1% and fluticasone propionate 0.005% in the treatment of atopic dermatitisFull text | PDF Volume 1 | Issue 2 | July-December 2022DOI: 10.25259/IJSA_4_2022 |
9,792 | 7,960 | 17,752 |
Letter to EditorInducible urticaria or skin lesions induced by Nd: YAG laser?Full text | PDF Volume 4 | Issue 1 | January-June 2025DOI: 10.25259/IJSA_41_2023 |
9,132 | 8,614 | 17,746 |
Original ArticleManagement of chronic spontaneous urticaria: Real-world Indian perspectiveFull text | PDF Volume 1 | Issue 1 | January-June 2022DOI: 10.25259/IJSA_4_2021 |
9,971 | 7,430 | 17,401 |
Review ArticleA review of biological agents and small molecules in the management of atopic dermatitisFull text | PDF Volume 2 | Issue 2 | July-December 2023DOI: 10.25259/IJSA_18_2023 |
9,922 | 7,250 | 17,172 |
Letter to EditorDasatinib-induced hand foot syndrome followed by bosutinib-induced photoallergic contact dermatitis in a patient of chronic myeloid leukemia: A rare co-occurrenceFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_1_2024 |
3,543 | 13,139 | 16,682 |
Letter to EditorHomemade lip injection for cosmetic purpose: A case reportFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_42_2023 |
3,106 | 13,423 | 16,529 |
SymposiumRole of moisturizers and cleansers in managing pediatric eczemaFull text | PDF Volume 4 | Issue 2 | July-December 2025DOI: 10.25259/IJSA_36_2025 |
14,314 | 2,165 | 16,479 |
Review ArticleLigelizumab: A novel molecule in the management of chronic spontaneous urticariaFull text | PDF Volume 2 | Issue 1 | January-June 2023DOI: 10.25259/IJSA_8_2023 |
8,600 | 7,500 | 16,100 |
Review ArticleBiomarkers of chronic spontaneous urticariaFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_14_2023 |
11,076 | 4,656 | 15,732 |
Original ArticleImpact of atopic dermatitis on quality of life in children and their families: A tertiary care hospital-based study from Northern IndiaFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_5_2024 |
5,362 | 9,921 | 15,283 |
Review ArticleChronic inducible urticaria: Clinical presentation, diagnosis, and managementFull text | PDF Volume 1 | Issue 1 | January-June 2022DOI: 10.25259/IJSA_12_2021 |
11,063 | 4,185 | 15,248 |
Review ArticleRole of patient-reported outcome measures in the management of chronic urticaria and angioedemaFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_6_2022 |
9,055 | 6,167 | 15,222 |
Letter to EditorHot car seat thermal burn: A must sought for differential diagnosis in summersFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_31_2024 |
4,062 | 11,072 | 15,134 |
ImagePacemaker dermatitis – A rare hypersensitivity reactionFull text | PDF Volume 4 | Issue 1 | January-June 2025DOI: 10.25259/IJSA_55_2024 |
8,190 | 6,761 | 14,951 |